<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153669</url>
  </required_header>
  <id_info>
    <org_study_id>R-0019/18</org_study_id>
    <nct_id>NCT04153669</nct_id>
  </id_info>
  <brief_title>Exercise With or Without Electrical Stimulation in Cystic Fibrosis (Part I): Effects on Physical Fitness</brief_title>
  <acronym>ECOMIRIN</acronym>
  <official_title>Effects of Exercise With or Without Electrical Stimulation in Physical Fitness in Cystic Fibrosis: an Integrated Vision (ECOMIRIN Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the effects of programmed exercise with or without electrical
      stimulation in the cardiorespiratory fitness, strength, functional capacity and agility in a
      group of young patients with Cystic Fibrosis: A randomized controlled trial comparing two
      interventions with a control group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">March 9, 2020</completion_date>
  <primary_completion_date type="Actual">March 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Strength</measure>
    <time_frame>Two assessment points throughout the study: baseline and 8 weeks after the intervention</time_frame>
    <description>Changes in strength will be measured using a five repetition maximum test (5RM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiorespiratory Fitness</measure>
    <time_frame>Two assessment points throughout the study:baseline and 8 weeks after the intervention</time_frame>
    <description>Changes in cardiorespiratory fitness will be measured using a cardiopulmonary exercise test (CPET)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Pulmonary Function</measure>
    <time_frame>Two assessment points throughout the study:baseline and 8 weeks after the intervention</time_frame>
    <description>Changes in pulmonary function will be measured using Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in physical activity levels</measure>
    <time_frame>Two assessment points throughout the study:baseline and 8 weeks after the intervention</time_frame>
    <description>Changes in physical activity levels will be measured using Physical Activity Questionnaire for Children and Adolescents (PAC-C or PAC-A)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>Two assessment points throughout the study:baseline and 8 weeks after the intervention</time_frame>
    <description>Changes in quality of life will be measures with the Cystic Fibrosis-Questionnaire-Revised (CFQ-R)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food consumption frequency</measure>
    <time_frame>One assessment point at baseline:baseline and 8 weeks after the intervention</time_frame>
    <description>The food consumption frequency will be measured using food frequency questionnaire (FFQ)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Cystic Fibrosis in Children</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise-No NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle.
The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise-NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will continue with regular visits to the specialist. This visits include recommendations to improve lifestyle.
The exercise protocol includes a concurrent exercise intervention (strength training and aerobic training), 3 days a week, 60 minutes sessions. Additionally, this group will receive neuromuscular electrical stimulation (NMES) concomitant to the strength training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise-NMES</intervention_name>
    <description>Exercise-NMES</description>
    <arm_group_label>Exercise-NMES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise-No NMES</intervention_name>
    <description>Exercise-No NMES</description>
    <arm_group_label>Exercise-No NMES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of CF

          -  Age: 6-18 years old

          -  Signature of informed consent of legal guardian and patient.

        Exclusion Criteria:

          -  Being a smoker

          -  Having had an exacerbation in the last 3 months

          -  Having undergone gastric surgery

          -  Having enteral nutrition at present

          -  The patients will come from the HIUNJ of Madrid.

          -  Currently taking CFTR modulators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margarita Perez Ruiz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Europea de Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Escuela de Doctorado e Investigacion, Universidad Europea</name>
      <address>
        <city>Villaviciosa De Od√≥n</city>
        <zip>28670</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Margarita Perez</investigator_full_name>
    <investigator_title>Full Professor in Exercise Physiology, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Electrostimulation</keyword>
  <keyword>Combined Training</keyword>
  <keyword>Physical Fitness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

